Strength and durability of antibody responses to BNT162b2 and CoronaVac

  1. Benjamin J. Cowling
  2. Irene O. L. Wong
  3. Eunice Y. C. Shiu
  4. Amber Y. T. Lai
  5. Samuel M. S. Cheng
  6. Sara Chaothai
  7. Kelvin K. H. Kwan
  8. Mario Martín-Sánchez
  9. Leo L. M. Poon
  10. Dennis K. M. Ip
  11. Gabriel M. Leung
  12. Nancy H. L. Leung
  13. J. S. Malik Peiris
1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

We studied 2780 adults in Hong Kong who received CoronaVac inactivated virus vaccine (Sinovac) and BNT162b2 mRNA vaccine (“Comirnaty”, BioNTech/Fosun Pharma). We found stronger and more durable antibody responses to two doses of the mRNA vaccine, and slightly stronger initial antibody responses to each vaccine in younger adults and women.

Related articles

Related articles are currently not available for this article.